These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7317745)
1. The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients. Kumar S; Costello CB; Glashan RW; Björklund B Br J Urol; 1981 Dec; 53(6):578-81. PubMed ID: 7317745 [TBL] [Abstract][Full Text] [Related]
2. Tumor markers (CEA, TPA and CA 19-9) in urine of bladder cancer patients. Tizzani A; Cassetta G; Cicigoi A; Piana P; Cerchier A; Pecchio F; Piantino P Int J Biol Markers; 1987; 2(2):121-4. PubMed ID: 3482861 [TBL] [Abstract][Full Text] [Related]
3. Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma. Carbin BE; Ekman P; Eneroth P; Nilsson B Urol Res; 1989; 17(5):269-72. PubMed ID: 2815427 [TBL] [Abstract][Full Text] [Related]
4. [Study on the measurement of urinary TPA]. Torizumi K; Yamada R; Ebisuno S; Fujinaga T Radioisotopes; 1984 Mar; 33(3):150-3. PubMed ID: 6473832 [No Abstract] [Full Text] [Related]
5. [Improvement of the determination of urinary tissue polypeptide antigen (TPA) and the clinical study in bladder cancer patients]. Morimoto S; Yoshida M; Yasukawa S; Uekado Y; Yoshida T; Aoshi H; Ebisuno S; Ohkawa T Nihon Hinyokika Gakkai Zasshi; 1988 Dec; 79(12):1954-61. PubMed ID: 3230746 [No Abstract] [Full Text] [Related]
6. Simultaneous determination of urinary CEA, ferritin and TPA in Egyptian bladder cancer patients. Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P Int J Biol Markers; 1992; 7(4):234-9. PubMed ID: 1491179 [TBL] [Abstract][Full Text] [Related]
7. [Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma]. Tizzani A; Casetta G; Cavallini A; Piana P; Piantino P Minerva Urol Nefrol; 1990; 42(2):69-71. PubMed ID: 2392743 [TBL] [Abstract][Full Text] [Related]
8. Tissue polypeptide antigen (TPA) in urinary bladder cancer cytology: a follow-up study. Senatore S; Zizzi L; Blasi C; Alfieri G; Saccani Jotti G; Gabrielli M; Luccarelli S Oncology; 1990; 47(1):37-42. PubMed ID: 2300382 [TBL] [Abstract][Full Text] [Related]
9. Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology. Bantis A; Zissimopoulos A; Sountoulides P; Giannakopoulos S; Kalaitzis C; Athanassiadou P; Agelonidou E; Touloupidis S Hell J Nucl Med; 2010; 13(3):213-7. PubMed ID: 21193872 [TBL] [Abstract][Full Text] [Related]
10. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients]. Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110 [TBL] [Abstract][Full Text] [Related]
11. [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers]. Ohmori H; Ohashi T; Aso Y; Kumamoto Y; Hisazumi H; Shiraiwa Y; Kurita T; Shimazaki J; Ohkawa T; Ogawa H Hinyokika Kiyo; 1988 Dec; 34(12):2101-10. PubMed ID: 3071123 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of tissue polypeptide antigen in the follow-up of bladder cancer. Menéndez López V; Galán JA; Fernández-Suárez A; López-Celada S; Alcover J; Filella X Urology; 2003 Aug; 62(2):243-8. PubMed ID: 12893327 [TBL] [Abstract][Full Text] [Related]
13. [Urinary tissue polypeptide antigen (TPA) in bladder cancer]. Fujinaga T; Kitamura S; Yoshida M Nihon Hinyokika Gakkai Zasshi; 1984 Jun; 75(6):959-66. PubMed ID: 6503117 [No Abstract] [Full Text] [Related]
14. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports. Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M Oncology; 1987; 44(2):118-23. PubMed ID: 2437508 [TBL] [Abstract][Full Text] [Related]
15. Tissue and serum TPA in subjects at risk for bladder cancer. Giovagnoli MR; Di Fraia P; Manna A; Marafini V; Valli C; Marchei P; Vecchione A Int J Biol Markers; 1989; 4(1):13-7. PubMed ID: 2746044 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors]. Kaneko K; Suzuki T; Takasaki E Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216 [TBL] [Abstract][Full Text] [Related]
17. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder]. Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679 [TBL] [Abstract][Full Text] [Related]
18. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer. Ecke TH; Lenk SV; Schlechte HH; Loening SA Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer]. Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513 [TBL] [Abstract][Full Text] [Related]
20. Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer. Adolphs HD; Oehr P Urol Res; 1984; 12(2):125-8. PubMed ID: 6740835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]